MSCI · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $3.13B | $2.86B | $2.53B | $2.25B | $2.04B | $1.70B | $1.56B | $1.43B |
| Cost of Revenue | — | — | — | — | — | $291.70M | $294.96M | $287.33M |
| Research & Development | $177.60M | $158.65M | $132.12M | $107.20M | $111.56M | $101.05M | $98.33M | $81.41M |
| Selling, General & Administrative | $180.22M | $182.34M | $153.97M | $146.86M | $147.89M | $114.63M | $110.09M | $99.88M |
| Operating Expenses | $1.42B | $1.33B | $1.14B | $1.04B | $970.82M | $810.63M | $802.10M | $747.09M |
| Operating Income | $1.71B | $1.53B | $1.38B | $1.21B | $1.07B | $884.76M | $755.70M | $686.90M |
| Interest Expense | — | — | $186.68M | $171.57M | $159.61M | $156.32M | $148.04M | $133.11M |
| Other Income / (Expense) | -$219.31M | -$172.35M | -$15.55M | -$163.80M | -$214.59M | -$198.54M | -$152.38M | -$57.00M |
| Income Before Taxes | $1.49B | $1.36B | $1.37B | $1.04B | $858.14M | $686.23M | $603.32M | $629.90M |
| Provision for Income Taxes | $291.95M | $247.04M | $220.47M | $173.27M | $132.15M | $84.40M | $39.67M | $122.01M |
| Net Income | $1.20B | $1.11B | $1.15B | $870.57M | $725.98M | $601.82M | $563.65M | $507.88M |
| Basic EPS | $15.72 | $14.09 | $14.45 | $10.78 | $8.80 | $7.19 | $6.66 | $5.83 |
| Diluted EPS | $15.69 | $14.05 | $14.39 | $10.72 | $8.70 | $7.12 | $6.59 | $5.66 |
| Basic Shares Outstanding | 76.50M | 78.71M | 79.46M | 80.75M | 82.51M | 83.72M | 84.64M | 87.18M |
| Diluted Shares Outstanding | 76.64M | 78.96M | 79.84M | 81.22M | 83.48M | 84.52M | 85.54M | 89.70M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $19.61 | $19.30 | $19.82 | 7 | ↑3 ↓4 |
| Dec 2027 | $22.35 | $21.80 | $22.76 | 7 | ↑3 ↓4 |
| Dec 2028 | $25.30 | $24.87 | $26.10 | 5 | ↑2 ↓0 |
| Dec 2029 | $28.44 | $28.15 | $28.86 | 3 | ↑1 ↓0 |